<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Moody Hollis | Activity</title>
	<link>https://recash.wpsoul.net/members/pocketgarden8/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/pocketgarden8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Moody Hollis.</description>
	<lastBuildDate>Wed, 20 May 2026 03:05:01 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a14bebfef2bd038c35c09ea9b6188d12</guid>
				<title>Moody Hollis posted an update: Results AKI developed in 10 of 32 patients (31.25%) who were [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/49225/</link>
				<pubDate>Wed, 11 Dec 2024 11:01:13 +0000</pubDate>

									<content:encoded><![CDATA[<p>Results AKI developed in 10 of 32 patients (31.25%) who were using vancomycin +&nbsp;piperacillin-tazobactam. On the other hand, 13 of 32 patients (40.62%) were using cefotaxime&nbsp;+ vancomycin (p = 0.047). Of the 10 patients who were on vancomycin&nbsp;+ piperacillin-tazobactam regimen, 80% developed AKI Stage I. Of the 13 patients who were using cefotaxime&nbsp;+&hellip;<span class="activity-read-more" id="activity-read-more-49225"><a href="https://recash.wpsoul.net/activity/p/49225/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2aa6d01278dd3a386ae4f338ffe658d2</guid>
				<title>Moody Hollis became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/49041/</link>
				<pubDate>Wed, 11 Dec 2024 10:38:11 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>